logo-crcmlogo-crcmlogo-crcmlogo-crcm
  • Home
  • Our center
    • Introducing the center
    • CRCM support services
    • Our commitments
      • Cellule R6Lab
      • Communication unit
      • CST unit (Thesis Monitoring Committee)
      • Integrity & Scientific Ethics Unit
      • Mentoring unit
      • Parity Professional Equality (PEP)
      • Psychosocial Risks Unit (RPS)
      • Social life unit
      • Animal Welfare Structure (SBEA)
    • Partnerships and Innovation
    • Our scientific network
  • Our research
    • Our research areas
      • Comet Department
      • Genome Integrity Department
      • OHIO Department
      • Translate-it Department
    • Our research teams
    • Our technology platforms
    • CRCM publications
  • For students
    • Studying at CRCM
    • Thesis / Master’s offers
    • Innovative cancer association for students in Marseille (ACIDEM)
    • Mentoring unit
    • News
    • Seminars
  • For scientists
    • News
    • Job offers
    • Seminars
    • Mentoring unit
    • Our alumni
  • Directory
  • The research teams
English
  • French
✕
10 February 2025
10 February 2025

Lignitto team deciphers BACH1 degradation mechanisms under oxidative stress

This publication in Cell reveals how two distinct E3 ligases target BACH1 quaternary degrons under oxidative stress, in collaboration with several research teams.
Do you like it?
Read more
28 January 2025
28 January 2025

Recent publications from the Modesti team: new perspectives on DNA repair and NHEJ

Recent publications by the Modesti team in Nat. Struct. Mol. Biol. and Nucleic Acids Res. reveal new DNA repair mechanisms, highlighting the role of disordered regions of XRCC4/XLF and the impact of Lig3 and Lig4 on cell viability.
Do you like it?
Read more
28 January 2025
28 January 2025

Coulon team identifies heterozygous RPA2 variant as new cause of telomere biology disorders

Published in Genes & Development, the Coulon team's study identifies a heterozygous variant of RPA2 as a new cause of disorders in telomere biology, impacting their stability and regulation.
Do you like it?
Read more
28 January 2025
28 January 2025

De Sepulveda team reveals kinase inactivity of MAN2A1-FER oncoprotein: tyrosine kinase inhibitors called into question

Published in Cellular and Molecular Gastroenterology and Hepatology, the De Sepulveda team's study demonstrates that the MAN2A1-FER oncoprotein, present in several cancers, lacks kinase activity, calling into question the efficacy of tyrosine kinase inhibitors as a therapeutic strategy.
Do you like it?
Read more
28 January 2025
28 January 2025

The Chames team deciphers the interaction between immune response and the efficiency of immune cell engagers

Published in ACS Nano, the study deciphers the impact of biophysical parameters and individual immune response on the efficacy of immune cell engagers, paving the way for optimizing their design in immunotherapy.
Do you like it?
Read more
3 December 2024
3 December 2024

Preprints and recent submissions from the Modesti team: promising work undergoing validation

Discover the latest research from the Modesti team, currently being evaluated by the scientific community. These studies explore key mechanisms of DNA repair and cell regulation.
Do you like it?
Read more

Filter by category

  • All categories
  • Comet Department
    • Bard team
    • Lignitto team
    • Borg / Maina team
    • Charafe / Ginestier team
    • Vandermoere team
    • Vasseur / Tomasini team
    • Zimmermann team
  • Genome Integrity Department
    • Gaillard team
    • Coulon team
    • Llorente team
    • Lachaud team
    • Modesti team
    • Pagès team
  • OHIO Department
    • Duprez team
    • Nunès / Devillier team
    • Sepulveda team
    • Aurand-Lions team
    • Chames team
    • Collette / Morelli team
  • Translate-it Department
    • Benzekry / Ciccolini team
    • Bertucci / Mamessier team
    • Dusetti / Iovanna team
    • Pasquier / André team
  • Technology platforms
    • Cytometry
  • CRCM articles
  • Scientific publication
  • Job offers
    • Internship
    • Other opportunities
    • PhD
    • PostDocs

Intranet connection
Directory
IPC Collaboration
News
Events
Partnerships and Innovation
Terms of use
Privacy policy

Marseille Cancer Research Center

27 Bd Leï Roure, CS 30059
13273 Marseille Cedex 09

Tel: 04 86 97 72 00

Contact us How to get here

Follow us

  • YouTube
  • LinkedIn
  • Bluesky
www.crcm-marseille.fr ©2024 | All rights reserved - Created by Yesss communication & Bioself
    English
    • English
    • French
        Manage consent

        To provide the best experiences, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent or withdrawing consent may adversely affect certain features and functions.

        Learn more

        Functional Always active
        Technical access or storage is strictly necessary for the legitimate interest purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
        Preferences
        Technical access or storage is necessary for the legitimate interest purpose of storing preferences that are not requested by the subscriber or Internet user.
        Statistics
        Storage or technical access that is used exclusively for statistical purposes. Technical storage or access that is used exclusively for anonymous statistical purposes. Absent a subpoena, voluntary compliance from your internet service provider, or additional records from a third party, information stored or retrieved for this sole purpose generally cannot be used to identify you.
        Marketing
        Technical access or storage is necessary to create user profiles in order to send advertisements, or to track the user on a website or across websites with similar marketing purposes.
        Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
        View preferences
        {title} {title} {title}